- Investing Ideas
- /
- Australian Pharmaceuticals & Biotech Large Cap High Growth Potential
Australian Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
1
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
1 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
CSL | AU$273.72 | -3.6% | 6.1% | AU$132.5b | AU$327.80 | PE32.7x | E13.0% | 1.5% |
Page 1 of 1